Foster, Talia; Miller, Jeffrey; Boye, Mark; Russell, Mason - In: PharmacoEconomics 27 (2009) 8, pp. 657-679
Follicular non-Hodgkin’s lymphoma (FNHL), a slow-growing cancer of the immune system, constitutes about 15–30% of all incident non-Hodgkin’s lymphoma in developed countries. Its incidence is rising worldwide. Patients can live many years, but FNHL is considered incurable. We systematically...